Aclaris Therapeutics, Inc. (ACRS)
6.22
-0.09
(-1.43%)
USD |
NASDAQ |
Aug 25, 09:55
Aclaris Therapeutics Market Cap : 869.71M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 882.29M |
| August 21, 2026 | 896.27M |
| August 20, 2026 | 885.09M |
| August 19, 2026 | 900.47M |
| August 18, 2026 | 881.59M |
| August 17, 2026 | 827.76M |
| August 14, 2026 | 808.18M |
| August 13, 2026 | 819.37M |
| August 12, 2026 | 816.57M |
| August 11, 2026 | 827.76M |
| August 10, 2026 | 824.96M |
| August 07, 2026 | 826.36M |
| August 06, 2026 | 851.53M |
| August 05, 2026 | 889.28M |
| August 04, 2026 | 836.15M |
| August 03, 2026 | 772.28M |
| July 31, 2026 | 726.19M |
| July 30, 2026 | 742.95M |
| July 29, 2026 | 715.02M |
| July 28, 2026 | 744.35M |
| July 27, 2026 | 749.94M |
| July 24, 2026 | 730.38M |
| July 23, 2026 | 765.30M |
| July 22, 2026 | 784.85M |
| July 21, 2026 | 794.62M |
| Date | Value |
|---|---|
| July 20, 2026 | 777.87M |
| July 17, 2026 | 793.23M |
| July 16, 2026 | 748.54M |
| July 15, 2026 | 782.06M |
| July 14, 2026 | 758.31M |
| July 13, 2026 | 768.09M |
| July 10, 2026 | 779.26M |
| July 09, 2026 | 797.42M |
| July 08, 2026 | 769.49M |
| July 07, 2026 | 784.85M |
| July 06, 2026 | 766.69M |
| July 02, 2026 | 776.47M |
| July 01, 2026 | 745.75M |
| June 30, 2026 | 738.76M |
| June 29, 2026 | 701.06M |
| June 26, 2026 | 698.26M |
| June 25, 2026 | 685.70M |
| June 24, 2026 | 668.94M |
| June 23, 2026 | 687.09M |
| June 22, 2026 | 675.92M |
| June 18, 2026 | 628.44M |
| June 17, 2026 | 617.27M |
| June 16, 2026 | 606.09M |
| June 15, 2026 | 608.89M |
| June 12, 2026 | 603.30M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 13.35B |
| Nektar Therapeutics | 2.576B |
| Xeris Biopharma Holdings, Inc. | 1.536B |
| Crinetics Pharmaceuticals, Inc. | 8.974B |
| Alumis, Inc. | 3.065B |
Market Cap Related Metrics
| PS Ratio | 97.78 |
| Price to Book Value | 6.981 |
| Price | 6.22 |
| Earnings Yield | -9.41% |